AtriCure, Inc. Cash and Restricted Cash
AtriCure, Inc. (ATRC) had Cash and Restricted Cash of $167.79 million as of 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-27
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $167.79M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $146.16M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $167.43M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $147.87M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $167.79M 10-Q · filed 2026-07-27 |
| 2026-03-31 | $146.16M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $167.43M 10-Q · filed 2026-07-27 |
| 2025-09-30 | $147.87M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $117.80M 10-Q · filed 2026-07-27 |
| 2025-03-31 | $99.89M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $122.72M 10-Q · filed 2026-07-27 |
| 2024-09-30 | $130.34M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $106.03M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $64.97M 10-Q · filed 2025-04-30 |
| 2023-12-31 | $84.31M 10-K · filed 2026-02-19 |
| 2023-09-30 | $80.60M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $67.24M 10-Q · filed 2024-07-31 |
| 2023-03-31 | $77.34M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $58.10M 10-K · filed 2026-02-19 |
| 2022-09-30 | $48.82M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $54.56M 10-Q · filed 2023-07-26 |
| 2022-03-31 | $28.14M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $43.65M 10-K · filed 2025-02-14 |
| 2021-09-30 | $39.89M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $67.62M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $85.38M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $41.94M 10-K · filed 2024-02-16 |
| 2020-09-30 | $33.38M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $28.48M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |